MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Substantia nigra dopaminergic neuron density in PD, PSP and MSA: An interim clinicopathological analysis

    E. Backman, L. Saari, M. Gardberg, V. Kaasinen (Turku, Finland)

    Objective: To investigate substantia nigra pars compacta (SNc) area together with dopaminergic neuron count and density in atypical parkinsonisms in relation to Parkinson’s disease (PD)…
  • 2022 International Congress

    Subgroup analyses by Unified Parkinson’s Disease Rating Scale Part III (UPDRS-III) of patients treated with levodopa inhalation powder 84mg or placebo to treat OFF symptoms in patients with Parkinson’s disease (PD)

    D. Grosset, P. Zhao, R. Marini, R. Cohen, B. Blank (Glasgow, United Kingdom)

    Objective: An analysis of the proportion of patients who turned ON after levodopa inhalation powder (CVT-301) 84mg treatment vs placebo, compared across subgroups of patients…
  • 2022 International Congress

    Gait Analysis in Normal Pressure Hydrocephalus: a Meta-Analysis

    M. Passaretti, A. Maranzano, B. Bluett, A. Fasano (Rome, Italy)

    Objective: This meta-analysis summarizes quantitative gait data in iNPH, and gait parameters improving after tap-test (TT)/CSF shunt surgery (CSS) to differentiate responders (R) from non-responders…
  • 2022 International Congress

    Non-motor fluctuations in People with Parkinson’s considering Deep Brain Stimulation surgery

    T. Turner, F. Rodriguez-Porcel, C. Cooper, V. Hinson, G. Revuelta (Charleston, USA)

    Objective: In this study we examine non-motor symptom (NMS) fluctuations reported by People with Parkinson’s (PWP) pursuing Deep Brain Stimulation (DBS) surgery using the MDS…
  • 2022 International Congress

    Levodopa-induced unilateral orofacial dystonia in multiple system atrophy : case report and video presentation

    C. Dong, H. Sun, S. Liu, P. Chan (Beijing, China)

    Objective: The study reports a case of lateral orofacial dystonia in a multiple system atrophy (MSA) patient treated with levodopa, and discusses the clinical characteristics…
  • 2022 International Congress

    The countless visual features in PD and their impact on quality of life. A standardized diagnostic protocol

    M. Meglio, E. Olivola, E. Palermo, G. Fioretto, D. D'Innocenzo, D. Centonze, N. Modugno (Pozzilli, Italy)

    Objective: Examine multiple aspects of visual functions in PD patients divided into subgroups by stage of disease to establish: the evidence of visual disorders, their…
  • 2022 International Congress

    Detection and Analysis of Spatio-Temporal Variables of Parkinsonian Gait Using PODOSmart® Insoles

    E. Ziagkas, A. Loukovitis, S. Bostantjopoulou, Z. Katsarou, G. Grouios (Thessaloniki, Greece)

    Objective: Objective: Typical Parkinsonian gait detection and analysis is heavily dependent on expensive sensors and human labor. Here we propose the use of PODOSmart® insoles,…
  • 2022 International Congress

    T1 posterior fossa radiomics based diagnosis of Essential tremor

    J. Saini, S. Prasad, A. Rajan, P. Pal, M. Ingalhalikar (Bangalore, India)

    Objective: To evaluate the utility of radiomics to differentiate essential tremor (ET) from healthy controls using radiomics features of the posterior fossa on routine T1…
  • 2022 International Congress

    Parkinson’s disease caregiver burden in rural India

    S. Desai, D. Desai, I. Prashnani (Anand, India)

    Objective: To assess the caregiver burden and factors determining it in patients with PD. To assess the anxiety and depression amongst caregivers. Background: Patients with…
  • 2022 International Congress

    Circadian cycle and disease phenotype in Parkinson’s disease, insights by motion sensors and molecular biology.

    M. Marano, A. Casamassa, M. Rossi, A. Magliozzi, Z. Yekutieli, A. Vescovi, J. Rosati, V. Di Lazzaro (Rome, Italy)

    Objective: Our aim is to investigate whether the circadian cycle (CC) is linked to the patient Parkinson's disease (PD) profile on a clinical and molecular…
  • « Previous Page
  • 1
  • …
  • 59
  • 60
  • 61
  • 62
  • 63
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley